Campbell & Co Investment Adviser’s Sharps Compliance Corp SMED Stock Holding History

Campbell & Co Investment Adviser’s Portfolio SMED Stock Details SMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-12,664	Closed	-$37K	–	1006
2022 Q2	$37K	Buy	+12,664	New	+$52.9K	0.01%	654
2022 Q1	–	Sell	-25,800	Closed	-$184K	–	965
2021 Q4	$184K	Buy	25,800 +9,700	+60%	+$74.5K	0.06%	546
2021 Q3	$133K	Buy	+16,100	New	+$150K	0.04%	553

Campbell & Co Investment Adviser's SMED Position: Q3 2022 in Review

Campbell & Co Investment Adviser sold out of Sharps Compliance Corp (SMED) in Q3 2022, closing a stake of 12,664 shares — an estimated $37K sold.

Campbell & Co Investment Adviser first reported a position in SMED in Q3 2021 and held it in 3 quarters. The position peaked at $184K in Q4 2021. 0 funds tracked by Wall St. Rank hold SMED as of Q3 2022.

Campbell & Co Investment Adviser reported no remaining Sharps Compliance Corp position as of Q3 2022 after selling out during the quarter.
Campbell & Co Investment Adviser sold 12,664 Sharps Compliance Corp shares in Q3 2022, an estimated $37K.
Campbell & Co Investment Adviser first reported a position in Sharps Compliance Corp in Q3 2021 and held it in 3 quarters.
Campbell & Co Investment Adviser's Sharps Compliance Corp position peaked at $184K in Q4 2021.
0 funds tracked by Wall St. Rank held Sharps Compliance Corp as of Q3 2022.

Based on Campbell & Co Investment Adviser's 13F filing for Q3 2022, filed 14 Nov 2022.